Jordan Hilgefort, MD
Sports Medicine · Louisville, KYNPI 1881042505
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 13 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Hydrocision, Inc. at 59.7% of the total.
Across 13 payments — averaging $58.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Hydrocision, Inc.$452
- Avanos Medical$133
- Abiomed$41
- Astellas Pharma US Inc$31
- Hologic Sales And Service, LLC$29
- Shield Therapeutics Inc$24
- plus $48 from 3 others
What the payments were for
- Food & beverage$758100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Hydrocision, Inc. | 4 | $452 |
| Avanos Medical | 1 | $133 |
| Abiomed | 1 | $41 |
| Astellas Pharma US Inc | 1 | $31 |
| Hologic Sales And Service, LLC | 2 | $29 |
| Shield Therapeutics Inc | 1 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Exact Sciences | 1 | $16 |
| Inogen, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$758 in reported general payments places this provider in the 55th percentile of 59 sports medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 37 | $47,533 |
| EliquisApixaban | 24 | $19,087 |
| LinzessLinaclotide | 14 | $11,978 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 24 | $7,703 |
| Advair HfaFluticasone Propion/Salmeterol | 22 | $6,017 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 17 | $3,269 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 19 | $2,355 |
| Atorvastatin Calcium | 164 | $1,120 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 31 | $1,105 |
| Ultra-Fine Short Pen NeedlePen Needle, Diabetic | 11 | $780 |
| Ventolin HfaAlbuterol Sulfate | 11 | $614 |
| Losartan Potassium | 82 | $539 |
| Levothyroxine Sodium | 36 | $511 |
| Metoprolol Succinate | 37 | $479 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $478 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Louisville
- Ryan KruppLouisville$803K
- Neil PatilLouisville$5K
- Scotty NewcomerLouisville$2K
- Paul McKeeLouisville$2K
- Gregory PottsLouisville$1K
- Robin CurryLouisville$1K
- Nathan McKinneyLouisville$686
- Mark PuckettLouisville$620
- Joshua WuLouisville$615
- William HughesLouisville$515
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.